Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis using a composite measure of disability: Integrated analysis of the phase 3 define and confirm studies

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: 830205e8fb2440080360e897fa1d4aee4ca5060b
First added on: Feb 07, 2025